Literature DB >> 26691695

Formation of DPM ethers using O-diphenylmethyl trichloroacetimidate under thermal conditions.

Kyle T Howard1, Brian C Duffy1, Matthew R Linaburg1, John D Chisholm1.   

Abstract

Alcohols are effectively converted to their corresponding diphenylmethyl (DPM) ethers by reaction with O-diphenylmethyl trichloroacetimidate in refluxing toluene without the requirement of a catalyst or other additives. A number of acid and base sensitive substrates were protected in excellent yield using this new method without disturbing the pre-existing functionality present in these molecules. This reaction is the first example of the formation of an ether from stoichiometric amounts of a trichloroacetimidate and an alcohol without the addition of a Brønsted or Lewis acid catalyst.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26691695      PMCID: PMC4986612          DOI: 10.1039/c5ob02455b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  22 in total

1.  Asymmetric glycolate aldol reactions using cinchonium phase-transfer catalysts.

Authors:  Merritt B Andrus; Jing Liu; Zhifeng Ye; John F Cannon
Journal:  Org Lett       Date:  2005-09-01       Impact factor: 6.005

2.  A novel acid-catalyzed O-benzylating reagent with the smallest unit of imidate structure.

Authors:  Kohei Yamada; Hikaru Fujita; Munetaka Kunishima
Journal:  Org Lett       Date:  2012-09-20       Impact factor: 6.005

3.  Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.

Authors:  A K Dutta; X S Fei; P M Beardsley; J L Newman; M E Reith
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

4.  Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors.

Authors:  Deog-Il Kim; Margaret M Schweri; Howard M Deutsch
Journal:  J Med Chem       Date:  2003-04-10       Impact factor: 7.446

5.  Total synthesis of the hydroxyketone kurasoin A using asymmetric phase-transfer alkylation.

Authors:  Merritt B Andrus; Erik J Hicken; Jeffrey C Stephens; D Karl Bedke
Journal:  J Org Chem       Date:  2006-10-27       Impact factor: 4.354

6.  Tuneable regioselectivity during the mono-etherification of the 2,3-diol of a mannose derivative.

Authors:  Sigthor Petursson; Sean M Scully; Sigridur Jonsdottir
Journal:  Carbohydr Res       Date:  2014-02-20       Impact factor: 2.104

7.  General approach to glycosidase inhibitors. Enantioselective synthesis of deoxymannojirimycin and swainsonine.

Authors:  Rubén Martín; Caterina Murruzzu; Miquel A Pericàs; Antoni Riera
Journal:  J Org Chem       Date:  2005-03-18       Impact factor: 4.354

8.  Synthesis of dopamine transporter selective 3-diarylmethoxymethyl-8-arylalkyl-8-azabicyclo[3.2.1]octane derivatives.

Authors:  Suhong Zhang; Sari Izenwasser; Dean Wade; Liang Xu; Mark L Trudell
Journal:  Bioorg Med Chem       Date:  2006-08-14       Impact factor: 3.641

9.  Phase-transfer-catalyzed asymmetric glycolate alkylation.

Authors:  Merritt B Andrus; Erik J Hicken; Jeffrey C Stephens
Journal:  Org Lett       Date:  2004-06-24       Impact factor: 6.005

10.  Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.

Authors:  John L Richardson; Isabelle R E Nett; Deuan C Jones; Mohamed H Abdille; Ian H Gilbert; Alan H Fairlamb
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

View more
  11 in total

1.  Friedel-Crafts Alkylation of Indoles with Trichloroacetimidates.

Authors:  Tamie Suzuki; John D Chisholm
Journal:  Tetrahedron Lett       Date:  2019-04-03       Impact factor: 2.415

2.  Ester Formation via Symbiotic Activation Utilizing Trichloroacetimidate Electrophiles.

Authors:  Nivedita S Mahajani; Rowan I L Meador; Tomas J Smith; Sarah E Canarelli; Arijit A Adhikari; Jigisha P Shah; Christopher M Russo; Daniel R Wallach; Kyle T Howard; Alexandra M Millimaci; John D Chisholm
Journal:  J Org Chem       Date:  2019-05-30       Impact factor: 4.354

3.  Alkylation of Sulfonamides with Trichloroacetimidates under Thermal Conditions.

Authors:  Daniel R Wallach; John D Chisholm
Journal:  J Org Chem       Date:  2016-08-10       Impact factor: 4.354

4.  Lewis Acid Catalyzed Displacement of Trichloroacetimidates in the Synthesis of Functionalized Pyrroloindolines.

Authors:  Arijit A Adhikari; John D Chisholm
Journal:  Org Lett       Date:  2016-08-03       Impact factor: 6.005

5.  Synthesis of 3,3'-Disubstituted Indolenines Utilizing the Lewis Acid Catalyzed Alkylation of 2,3-Disubstituted Indoles with Trichloroacetimidates.

Authors:  Arijit A Adhikari; Léa Radal; John D Chisholm
Journal:  Synlett       Date:  2017-07-11       Impact factor: 2.454

6.  Rearrangement of Benzylic Trichloroacetimidates to Benzylic Trichloroacetamides.

Authors:  Arijit A Adhikari; Tamie Suzuki; Reesheda T Gilbert; Matthew R Linaburg; John D Chisholm
Journal:  J Org Chem       Date:  2017-03-27       Impact factor: 4.354

7.  A Convenient Protecting Group for Uridine Ureido Nitrogen: (4,4'-Bisfluorophenyl)methoxymethyl group.

Authors:  Katsuhiko Mitachi; David Mingle; Michio Kurosu
Journal:  Synthesis (Stuttg)       Date:  2021-03-25       Impact factor: 2.969

8.  Promoter free allylation of trichloroacetimidates with allyltributylstannanes under thermal conditions to access the common 1,1'-diarylbutyl pharmacophore.

Authors:  Nivedita S Mahajani; John D Chisholm
Journal:  Org Biomol Chem       Date:  2018-05-30       Impact factor: 3.876

9.  Synthesis of 1,1'-Diarylethanes and Related Systems by Displacement of Trichloroacetimidates with Trimethylaluminum.

Authors:  Nivedita S Mahajani; John D Chisholm
Journal:  J Org Chem       Date:  2018-03-08       Impact factor: 4.354

10.  Formation of Pyrroloindolines via the Alkylation of Tryptamines with Trichloroacetimidates.

Authors:  Bhaskar D Joshi; John D Chisholm
Journal:  Tetrahedron Lett       Date:  2021-07-01       Impact factor: 2.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.